AS-1763

  Cat. No.:  DC47718   Featured
Chemical Structure
2227211-00-7
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
AS-1763 is an orally available, potent, and selective BTK inhibitor and shows excellent potency against both wild/C481S mutant BTKs with IC50 of 0.85 nM/0.99 nM.
Cas No.: 2227211-00-7
Chemical Name: US10793575, Example 23
Synonyms: BDBM465748;US10793575, Example 23;2-(3-{2-amino-6-[1-(oxetan-3-yl)-1,2,3,6-tetrahydropyridin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}-2-(hydroxymethyl)phenyl)-6-cyclopropyl-8-fluoroisoquinolin-1(2H)-one
SMILES: FC1=C2C(N(C3=C([H])C([H])=C([H])C(=C3C([H])([H])O[H])C3=C4C(=NC(N([H])[H])=N3)N([H])C(=C4[H])C3=C([H])C([H])([H])N(C([H])([H])C3([H])[H])C3([H])C([H])([H])OC3([H])[H])C([H])=C([H])C2=C([H])C(=C1[H])C1([H])C([H])([H])C1([H])[H])=O
Formula: C33H31FN6O3
M.Wt: 578.6361
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC47718 AS-1763 AS-1763 is an orally available, potent, and selective BTK inhibitor and shows excellent potency against both wild/C481S mutant BTKs with IC50 of 0.85 nM/0.99 nM.
DC11471 BGB-3111(Zanubrutinib) Zanubrutinib is a selective Bruton tyrosine kinase (BTK) inhibitor.
DC10044 ONO4059 analog The product is the analog of ONO-4059, ONO-4059 is a highly potent and selective Btk inhibitor with an IC50 in the sub-nM range.
DC5146 RN486 RN-486 is a Bruton's tyrosine kinase (Btk) inhibitor.
DC1106 PCI-32765 (Ibrutinib) PCI-32765 (Ibrutinib) is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM.
DC10757 PCI-29732 PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.
DC10043 ONO4059 hydrochloride ONO-4059 is a highly selective, orally bioavailable BTK inhibitor with a potency (IC50) of 2.2 nM.
DC7937 LFM-A13 FM-A13 is a selective inhibitor of Bruton’s tyrosine kinase (BTK) – IC₅₀’s = 2.5 µM (recombinant BTK) and 17.2 µM (human BTK).
DC10380 Evobrutinib Evobrutinib is an inhibitor of Bruton's tyrosin kinase (Btk) inhibitor extracted from patent US20140162983 example 0174.
DC7380 CGI-1746 CGI1746 is a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation.
X